Abbott receives Brazilian antitrust approval to buy Alere
MLex Summary: Drugmaker Abbott Laboratories has received antitrust clearance, without conditions, in Brazil to buy diagnostic test maker Alere Incorporated for $5.8 billion, according to a statement disclosed today in the case file....To view the full article, register now.
Already a subscriber? Click here to view full article